About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘lack of IRB approval’ Category

ORI, OHRP find “some human subject issues” in Henschke lung cancer studies, but no evidence of misconduct

with one comment

cancerWe have an update on two papers about lung cancer screening by Claudia Henschke and colleagues that were subject to an Expression of Concern early last year.

The original Expression of Concern in Cancer read, in part: Read the rest of this entry »

About these ads

New Mexico obstetrics researcher violated research subject protocols: Retraction notice

leave a comment »

gynoncLaurence Cole, an obstetrics researcher at the University of New Mexico, made an appearance on this blog in November 2011 after the American Journal of Obstetrics & Gynecology published a remarkably heavy-handed retraction of one of his papers.

Shortly after, we learned that the retraction was preceded by a strongly-worded letter from an attorney representing a company that had been miffed by the content of Cole’s article (the issue involved the effectiveness of commercially-available pregnancy tests, and Cole’s failure to adequately disclose a past relationship with the aggrieved company’s competitor). That letter read, in part: Read the rest of this entry »

IRB issues force retraction of ulcer bug bacteria paper

leave a comment »

jpgnA group of Turkish researchers has had a paper retracted on how to treat the bacterium that cause ulcers after the journal’s editors found “issues related to the institutional review board approval” of the project.

Here’s the retraction notice from the Journal of Pediatric Gastroenterology and Nutrition: Read the rest of this entry »

Social sciences paper retracted for lack of ethical approval

with 13 comments

social science and medicineA University of Minnesota social scientist who studies health disparities has retracted a study that apparently lacked ethical approval.

Here’s the notice for “Deservingness to state health services for South – South migrants: A preliminary study of Costa Rican providers’ views,” a paper in Social Science & Medicine by Kate Goldade and a colleague: Read the rest of this entry »

Written by Ivan Oransky

February 25, 2013 at 2:01 pm

Retraction record broken, again: University report should up Fujii total to 183

leave a comment »

a&amisconductcoverKeeping up with the various investigations into the activities of Yoshitaka Fujii — the assumed record holder for retractions by a single author, with 172 likely — can be a challenge. Between the journals pulling his papers and the institutions looking into his misconduct, it’s hard to keep everything straight.

But we have a new report, from a past employer, that makes for interesting reading and helps tie up some loose ends. The document is from Tsukuba University, where Fujii worked more than a decade ago when questions about the propriety of his findings first surfaced. Read the rest of this entry »

Two Moriguchi stem cell papers being retracted

with 6 comments

It was, as Nature News wrote last month, a story that “seemed too good to be true:”

Stem-cell transplant claims debunked

Transplant of induced pluripotent stem cells to treat heart failure probably never happened

Hisashi Moriguchi, a visiting researcher at the University of Tokyo, had claimed a result that would have put him years ahead of researchers toiling in stem cell research. But the claims were met with a great deal of doubt — to say the least — and the story began to unravel when Harvard, where Moriguchi said he’d done the work, denied it had ever taken place.

And as expected, the retractions have now started. Today, a Nature Publishing Group journal said they would be retracting two papers, “A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals” and “Successful cryopreservation of human ovarian cortex tissues using supercooling.” The notices for the Scientific Reports papers will both say the same thing: Read the rest of this entry »

PLoS ONE retracts paper on treatment of tissue disease for lack of ethical approval, erroneous data

leave a comment »

PLOS ONE has retracted an article it published earlier this year by a group from Australia who failed to receive adequate ethics approval for their study.

The paper, “Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren’s Disease,” came from Warren M. Rozen, Yasith Edirisinghe and John Crock (sorry, irony machine not working today). Dupuytren’s causes thickening of the fascia in the hands and often requires surgery.  In 2011 the FDA approved a treatment for the ailment that involves injections of an enzyme — Clostridium Histolyticum Collagenase, or CHC — into the affected area.

The Aussie article looked at the effects of CHC injections in 12 patients over one year, finding that two of the patients suffered Read the rest of this entry »

Another odd retraction for alcohol researcher, this time for lack of animal research committee approval

with one comment

The journal Neuroscience has retracted a 2011 paper by an alcohol researcher from the United Arab Emirates, who apparently conducted some mouse studies without the blessing of his institution’s animal ethics officials. At least, that’s what the retraction notice would have us believe.

The paper in question, “The pre-synaptic metabotropic glutamate receptor 7 “mGluR7” is a critical modulator of ethanol sensitivity in mice,” by Amine Bahi, was published in December 2011 and cited three times (twice by the author), according to Thomson Scientific’s Web of Knowledge. But as the notice explains:

Read the rest of this entry »

Another retraction from chiropractic researchers for lack of ethics approval

with 6 comments

Chiropractic & Manual Therapies — formerly known as Chiropractic & Osteopathy — has retracted a 2010 paper by a team of Australian researchers who failed to obtain institutional review board (IRB) approval for their studies.

As the notice for “A descriptive study of a manual therapy intervention within a randomised controlled trial for hamstring and lower limb injury prevention” explains: Read the rest of this entry »

Hip, hip, hooray! Hip journal retracts paper that had, well, everything wrong with it

with 14 comments

Sometimes, you just gotta retract.

Here’s the retraction notice for “Outcome of short proximal femoral nail antirotation and dynamic hip screw for fixation of unstable trochanteric fractures. A randomised prospective comparative trial,” originally published in Hip International in 2011 by a group of researchers at the All India Institute of Medical Sciences in New Delhi: Read the rest of this entry »

Follow

Get every new post delivered to your Inbox.

Join 33,747 other followers